Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study
<i>Background and Objectives:</i> In this study, we assessed the utility of ultrasonography in monitoring the chemotherapeutic effects on primary thyroid lymphoma (PTL). <i>Materials and Methods:</i> This retrospective analysis included 17 patients with PTL who received chemo...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/61/1/15 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832588022465429504 |
---|---|
author | Shirong Liu Ying Fu Ligang Cui Shumin Wang Shi Tan |
author_facet | Shirong Liu Ying Fu Ligang Cui Shumin Wang Shi Tan |
author_sort | Shirong Liu |
collection | DOAJ |
description | <i>Background and Objectives:</i> In this study, we assessed the utility of ultrasonography in monitoring the chemotherapeutic effects on primary thyroid lymphoma (PTL). <i>Materials and Methods:</i> This retrospective analysis included 17 patients with PTL who received chemotherapy from 2012 to 2022. The sonographic features were examined pre- and post-treatment using ultrasound (US) to monitor the treatment response at the first to second, third to fourth, and end cycles of chemotherapy and follow-up, and progression-free survival (PFS) and overall survival (OS) were analyzed. <i>Results:</i> The sonographic findings for all the patients indicated diffuse or nodular infiltration with markedly hypoechoic masses, and “stripe-shaped” high echoes and posterior acoustic enhancement were observed. Following one to two cycles of chemotherapy, a US examination revealed varying tumor reduction degrees and diminished blood flow signals. After three to four cycles of chemotherapy, the US demonstrated an evaluation efficacy comparable to that of PET-CT in cases in which the lesion had entirely disappeared postchemotherapy; however, its ability to differentiate between treatment response and residual lesions was less effective compared to that of PET-CT. After the end cycle of chemotherapy, the lesion sizes had significantly decreased compared to those at the baseline (<i>p</i> < 0.05). Postchemotherapy, Adler’s blood flow grades decreased significantly, with 80% graded as 0–1. Among the 10 patients with cervical lymph node enlargement, 70% showed reduced lesion sizes and blood flow signals. The cumulative 5-year PFS and OS rates were both 80% for the diffuse type and 82.5% and 78.8% for the nodular type, respectively (<i>p</i> > 0.05). <i>Conclusions:</i> US can be utilized to monitor the therapeutic response following chemotherapy for PTL, especially for early assessment and repeated dynamic monitoring, and can serve as a complementary follow-up method to PET-CT. |
format | Article |
id | doaj-art-d439d8125cef4a0ebe04151eeb854727 |
institution | Kabale University |
issn | 1010-660X 1648-9144 |
language | English |
publishDate | 2024-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Medicina |
spelling | doaj-art-d439d8125cef4a0ebe04151eeb8547272025-01-24T13:40:15ZengMDPI AGMedicina1010-660X1648-91442024-12-016111510.3390/medicina61010015Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective StudyShirong Liu0Ying Fu1Ligang Cui2Shumin Wang3Shi Tan4Department of Ultrasound, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Ultrasound, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Ultrasound, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Ultrasound, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Ultrasound, Peking University Third Hospital, Beijing 100191, China<i>Background and Objectives:</i> In this study, we assessed the utility of ultrasonography in monitoring the chemotherapeutic effects on primary thyroid lymphoma (PTL). <i>Materials and Methods:</i> This retrospective analysis included 17 patients with PTL who received chemotherapy from 2012 to 2022. The sonographic features were examined pre- and post-treatment using ultrasound (US) to monitor the treatment response at the first to second, third to fourth, and end cycles of chemotherapy and follow-up, and progression-free survival (PFS) and overall survival (OS) were analyzed. <i>Results:</i> The sonographic findings for all the patients indicated diffuse or nodular infiltration with markedly hypoechoic masses, and “stripe-shaped” high echoes and posterior acoustic enhancement were observed. Following one to two cycles of chemotherapy, a US examination revealed varying tumor reduction degrees and diminished blood flow signals. After three to four cycles of chemotherapy, the US demonstrated an evaluation efficacy comparable to that of PET-CT in cases in which the lesion had entirely disappeared postchemotherapy; however, its ability to differentiate between treatment response and residual lesions was less effective compared to that of PET-CT. After the end cycle of chemotherapy, the lesion sizes had significantly decreased compared to those at the baseline (<i>p</i> < 0.05). Postchemotherapy, Adler’s blood flow grades decreased significantly, with 80% graded as 0–1. Among the 10 patients with cervical lymph node enlargement, 70% showed reduced lesion sizes and blood flow signals. The cumulative 5-year PFS and OS rates were both 80% for the diffuse type and 82.5% and 78.8% for the nodular type, respectively (<i>p</i> > 0.05). <i>Conclusions:</i> US can be utilized to monitor the therapeutic response following chemotherapy for PTL, especially for early assessment and repeated dynamic monitoring, and can serve as a complementary follow-up method to PET-CT.https://www.mdpi.com/1648-9144/61/1/15lymphomathyroid neoplasmsdopplerultrasonography |
spellingShingle | Shirong Liu Ying Fu Ligang Cui Shumin Wang Shi Tan Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study Medicina lymphoma thyroid neoplasms doppler ultrasonography |
title | Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study |
title_full | Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study |
title_fullStr | Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study |
title_full_unstemmed | Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study |
title_short | Role of Ultrasonography in Monitoring Chemotherapeutic Effects on Primary Thyroid Lymphoma: A Single-Center Retrospective Study |
title_sort | role of ultrasonography in monitoring chemotherapeutic effects on primary thyroid lymphoma a single center retrospective study |
topic | lymphoma thyroid neoplasms doppler ultrasonography |
url | https://www.mdpi.com/1648-9144/61/1/15 |
work_keys_str_mv | AT shirongliu roleofultrasonographyinmonitoringchemotherapeuticeffectsonprimarythyroidlymphomaasinglecenterretrospectivestudy AT yingfu roleofultrasonographyinmonitoringchemotherapeuticeffectsonprimarythyroidlymphomaasinglecenterretrospectivestudy AT ligangcui roleofultrasonographyinmonitoringchemotherapeuticeffectsonprimarythyroidlymphomaasinglecenterretrospectivestudy AT shuminwang roleofultrasonographyinmonitoringchemotherapeuticeffectsonprimarythyroidlymphomaasinglecenterretrospectivestudy AT shitan roleofultrasonographyinmonitoringchemotherapeuticeffectsonprimarythyroidlymphomaasinglecenterretrospectivestudy |